Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Total Current Liabilities (2016 - 2026)

Organogenesis Holdings has reported Total Current Liabilities over the past 11 years, most recently at $100.1 million for Q4 2025.

  • For Q4 2025, Total Current Liabilities rose 29.23% year-over-year to $100.1 million; the TTM value through Dec 2025 reached $100.1 million, up 29.23%, while the annual FY2025 figure was $100.1 million, 29.23% up from the prior year.
  • Total Current Liabilities for Q4 2025 was $100.1 million at Organogenesis Holdings, up from $90.3 million in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $100.1 million in Q4 2025 and troughed at $65.1 million in Q1 2025.
  • A 5-year average of $80.5 million and a median of $80.8 million in 2021 define the central range for Total Current Liabilities.
  • Biggest five-year swings in Total Current Liabilities: skyrocketed 34.99% in 2021 and later fell 23.2% in 2025.
  • Year by year, Total Current Liabilities stood at $82.7 million in 2021, then decreased by 9.29% to $75.0 million in 2022, then rose by 7.31% to $80.5 million in 2023, then fell by 3.77% to $77.5 million in 2024, then grew by 29.23% to $100.1 million in 2025.
  • Business Quant data shows Total Current Liabilities for ORGO at $100.1 million in Q4 2025, $90.3 million in Q3 2025, and $65.8 million in Q2 2025.